Journal Title：Journal Of Integrative Medicine-jim

The predecessor of JIM is the Journal of Chinese Integrative Medicine (Zhong Xi Yi Jie He Xue Bao). With this new, English-language publication, we are committed to make JIM an international platform for publishing high-quality papers on complementary and alternative medicine (CAM) and an open forum in which the different professions and international scholarly communities can exchange views, share research and their clinical experience, discuss CAM education, and confer about issues and problems in our various disciplines and in CAM as a whole in order to promote integrative medicine.

JIM is indexed/abstracted in: MEDLINE/PubMed, ScienceDirect, Emerging Sources Citation Index (ESCI), Scopus, Embase, Chemical Abstracts (CA), CAB Abstracts, EBSCO, WPRIM, JST China, Chinese Science Citation Database (CSCD), and China National Knowledge Infrastructure (CNKI).

JIM Editorial Office uses ThomsonReuters ScholarOne Manuscripts as submitting and review system (submission link: http://mc03.manuscriptcentral.com/jcim-en).

JIM is published bimonthly. Manuscripts submitted to JIM should be written in English. Article types include but are not limited to randomized controlled and pragmatic trials, translational and patient-centered effectiveness outcome studies, case series and reports, clinical trial protocols, preclinical and basic science studies, systematic reviews and meta-analyses, papers on methodology and CAM history or education, conference proceedings, editorials, commentaries, short communications, book reviews, and letters to the editor.

Our purpose is to publish a prestigious international journal for studies in integrative medicine. To achieve this aim, we seek to publish high-quality papers on any aspects of integrative medicine, such as acupuncture and traditional Chinese medicine, Ayurveda medicine, herbal medicine, homeopathy, nutrition, chiropractic, mind-body medicine, taichi, qigong, meditation, and any other modalities of CAM; our commitment to international scope ensures that research and progress from all regions of the world are widely covered. These ensure that articles published in JIM have the maximum exposure to the international scholarly community.

JIM can help its authors let their papers reach the widest possible range of readers, and let all those who share an interest in their research field be concerned with their study.

JIM的前身是《中西醫(yī)結(jié)合雜志》。憑借這一新的英文出版物，我們致力于將 JIM 打造成一個(gè)發(fā)表補(bǔ)充和替代醫(yī)學(xué) (CAM) 高質(zhì)量論文的國(guó)際平臺(tái)和一個(gè)開(kāi)放的論壇，不同專業(yè)和國(guó)際學(xué)術(shù)界可以在此交流意見(jiàn)、分享研究和臨床經(jīng)驗(yàn)、討論 CAM 教育，并就我們各個(gè)學(xué)科和 CAM 整體中的問(wèn)題和困難進(jìn)行討論，以促進(jìn)綜合醫(yī)學(xué)的發(fā)展。

JIM 被以下數(shù)據(jù)庫(kù)收錄/摘要：MEDLINE/PubMed、ScienceDirect、新興資源引文索引 (ESCI)、Scopus、Embase、化學(xué)文摘 (CA)、CAB Abstracts、EBSCO、WPRIM、JST China、中國(guó)科學(xué)引文數(shù)據(jù)庫(kù) (CSCD) 和中國(guó)國(guó)家知識(shí)基礎(chǔ)設(shè)施 (CNKI)。

JIM 編輯部使用 ThomsonReuters ScholarOne Manuscripts 作為提交和審查系統(tǒng)（提交鏈接： http://mc03.manuscriptcentral.com/jcim-en)。

JIM 每?jī)蓚€(gè)月出版一次。提交給 JIM 的稿件應(yīng)以英文撰寫。文章類型包括但不限于隨機(jī)對(duì)照和實(shí)用試驗(yàn)、轉(zhuǎn)化和以患者為中心的有效性結(jié)果研究、病例系列和報(bào)告、臨床試驗(yàn)方案、臨床前和基礎(chǔ)科學(xué)研究、系統(tǒng)評(píng)價(jià)和薈萃分析、方法論和 CAM 歷史或教育論文、會(huì)議論文集、社論、評(píng)論、簡(jiǎn)短通訊、書(shū)評(píng)和致編輯的信。

我們的目的是出版一本享有盛譽(yù)的綜合醫(yī)學(xué)研究國(guó)際期刊。為了實(shí)現(xiàn)這一目標(biāo)，我們尋求發(fā)表關(guān)于綜合醫(yī)學(xué)任何方面的高質(zhì)量論文，例如針灸和傳統(tǒng)中醫(yī)、阿育吠陀醫(yī)學(xué)、草藥、順勢(shì)療法、營(yíng)養(yǎng)學(xué)、脊椎按摩療法、身心醫(yī)學(xué)、太極、氣功、冥想和任何其他 CAM 模式；我們對(duì)國(guó)際范圍的承諾確保了來(lái)自世界各個(gè)地區(qū)的研究和進(jìn)展得到廣泛報(bào)道。這確保了在 JIM 上發(fā)表的文章能夠最大限度地接觸到國(guó)際學(xué)術(shù)界。

JIM 可以幫助作者讓他們的論文接觸到盡可能廣泛的讀者，并讓所有對(duì)他們的研究領(lǐng)域感興趣的人關(guān)注他們的研究。

Journal Of Integrative Medicine-jim創(chuàng)刊于2003年，由Elsevier出版商出版，收稿方向涵蓋Medicine - Complementary and Alternative Medicine全領(lǐng)域，此刊是該細(xì)分領(lǐng)域中屬于非常不錯(cuò)的SCI期刊，在行業(yè)細(xì)分領(lǐng)域中學(xué)術(shù)影響力較大，專業(yè)度認(rèn)可很高，所以對(duì)原創(chuàng)文章要求創(chuàng)新性較高，如果您的文章質(zhì)量很高，可以嘗試。平均審稿速度 ，影響因子指數(shù)4.2，該期刊近期沒(méi)有被列入國(guó)際期刊預(yù)警名單，廣大學(xué)者值得一試。